# Endogenous Opioid Modulation by Ketamine

> **NCT03051945** · PHASE3 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine Hydrochloride
- **OTHER:** Normal saline

## Key facts

- **NCT ID:** NCT03051945
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-08
- **Primary completion:** 2019-08-01
- **Final completion:** 2019-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to perform brain imaging
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03051945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03051945, "Endogenous Opioid Modulation by Ketamine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03051945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*